首页 | 本学科首页   官方微博 | 高级检索  
     

以奥沙利铂为主联合化疗晚期胃癌的研究
引用本文:叶书成,袁国珍,郝万红,徐刚,张建光,张长虹. 以奥沙利铂为主联合化疗晚期胃癌的研究[J]. 临床荟萃, 2005, 20(20): 1150-1152
作者姓名:叶书成  袁国珍  郝万红  徐刚  张建光  张长虹
作者单位:淄博万杰医院,肿瘤科,山东,淄博,255213
摘    要:目的比较奥沙利铂、亚叶酸钙及氟尿嘧啶与顺铂、亚叶酸钙及氟尿嘧啶联合化疗对晚期胃癌的疗效和不良反应.方法 108例患者被随机分入两组,A组56例,B组52例.A组:奥沙利铂130 mg/m^2,静脉滴注4小时,第1天;亚叶酸钙200 mg/m^2,静脉滴注2小时,第1~5天;氟尿嘧啶300 mg/m^2,静脉滴注4小时,第1~5天.B组:顺铂80 mg/m^2,静脉滴注2小时,第1天;亚叶酸钙200 mg/m^2,静脉滴注2小时,第1~5天;氟尿嘧啶300 mg/m^2,静脉滴注4小时,第1~5天.3周为1周期,3周期为1疗程.结果 A组有效率60.7%,中位生存时间13.0个月,B组有效率53.8%,中位生存时间11.5个月(P〉0.05).有效患者的中位缓解期分别是7.8个月和5.5个月,差异有统计学意义(P<0.05).A组较B组消化道反应、血液毒性有明显的下降(P<0.05).A组中神经毒性出现较多(P<0.05).结论奥沙利铂、亚叶酸钙及氟尿嘧啶联合化疗方案治疗晚期胃癌临床疗效肯定,值得进一步研究.

关 键 词:胃肿瘤 奥沙利铂 亚叶酸钙 氟尿嘧啶 药物疗法  联合
文章编号:1004-583X(2005)20-1150-03
收稿时间:2005-03-08
修稿时间:2005-03-082005-07-11

Clinical study of oxaliplatin,fluorouracil and leucovorin regimen in chemotherapy for advanced gastric cancer
YE Shu-cheng,YUAN Guo-zhen,HAO Wan-hong,XU Gang,ZHANG Jian-guang,ZHANG Chang-hong. Clinical study of oxaliplatin,fluorouracil and leucovorin regimen in chemotherapy for advanced gastric cancer[J]. Clinical Focus, 2005, 20(20): 1150-1152
Authors:YE Shu-cheng  YUAN Guo-zhen  HAO Wan-hong  XU Gang  ZHANG Jian-guang  ZHANG Chang-hong
Affiliation:Department of Oncology ,Wanjie Hospital ,Zibo Shandong 255213,China
Abstract:Objective To evaluate which is the better regimen in chemotherapy for advanced gastric cancer.Methods One hundred and eight patients with advanced gastric cancer were divided into two groups randomly (group A 56 patients and group B 52 patients).The regimen of the group A was oxaliplatin 130 mg/m~2,iv infusion for 4 hours on day 1; leucovorin 200 mg/m~2,iv infusion for 2 hours followed by 5-fluorouracil 300 mg/m~2,for 4 hours from day 1 to 5.The regimen of the group B was cisiplatin 80 mg/m~2,iv infusion for 2 hours on day 1; LV 200 mg/m~2,iv infusion for 2 hours followed by 5-fluorouracil 300 mg/m~2,for 4 hours from day 1 to 5.All patients finished three cycles (three weeks per cycle).Results The response rate (RR) was (60.7%) in group A and (53.8%) in group B (P>(0.05)); The median survival time was 13 months in group A and (11.5) months in group B (P>(0.05)); The median time to progression was (7.8) months in group A and (5.5) months in group B (P<(0.05)),respectively.The toxicity of vomiting and leukopenia was decreased in group A (P<(0.05)),and the neuro-sensory toxicity was increased in group A (P<(0.05)).Conclusion Oxaliplatin combination 5-fluorouracil/leucovorin yields an encouraging response with acceptable toxicity for advanced gastric cancer,further clinical research is worthwhile.
Keywords:advanced gastric cancer   oxaliplatin   leucovorin   fluorouracil
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号